Clinical Trials Browser

Phase 2 × Non-Squamous Non-Small Cell Lung Cancer × Docetaxel × Clear all

NCT01204697 2015-11-16

A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)

Phase 2 Completed

74 enrolled 12 charts

Non-Squamous Non-Small Cell Lung Cancer